Lonza Group AG Share Price Deutsche Boerse AG
Equities
LO3
CH0013841017
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
293.9 EUR | +1.48% | -.--% | -.--% |
18/04 | Global markets live: DocMorris, Microsoft, Oracle, Micron, Netflix... | |
18/04 | Lonza Finance Launches EUR1 Billion 12-Year Euro Bond | DJ |
Sales 2024 * | 6.64B 7.28B 6.8B 607B | Sales 2025 * | 7.44B 8.16B 7.62B 680B | Capitalization | 36.81B 40.33B 37.66B 3,364B |
---|---|---|---|---|---|
Net income 2024 * | 904M 991M 925M 82.61B | Net income 2025 * | 1.11B 1.22B 1.14B 102B | EV / Sales 2024 * | 5.87 x |
Net Debt 2024 * | 2.18B 2.38B 2.23B 199B | Net Debt 2025 * | 2.47B 2.71B 2.53B 226B | EV / Sales 2025 * | 5.28 x |
P/E ratio 2024 * |
41.3
x | P/E ratio 2025 * |
33.1
x | Employees | 18,000 |
Yield 2024 * |
0.88% | Yield 2025 * |
1.01% | Free-Float | 95.87% |
Latest transcript on Lonza Group AG
1 day | +1.48% |
Managers | Title | Age | Since |
---|---|---|---|
Albert Baehny
CEO | Chief Executive Officer | 72 | 25/17/25 |
Philippe Deecke
DFI | Director of Finance/CFO | 52 | 01/21/01 |
Maria Nunez
COO | Chief Operating Officer | 55 | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Barbara Richmond
BRD | Director/Board Member | 63 | 16/14/16 |
Director/Board Member | 66 | 16/14/16 | |
Marion Helmes
BRD | Director/Board Member | 58 | 05/22/05 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.67% | 42.4B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B | |
-4.38% | 9.5B |
- Stock Market
- Equities
- LONN Stock
- LO3 Stock